Hormone therapy (HT) optimization in your postmenopausal patients requires an evidence-based approach in order to maximize benefits and minimize risks associated with available therapies. This white paper provides a thorough review of clinical studies on progesterone (P4) treatment options in menopause in the context of safeguarding endometrial health. Laboratory testing options to guide therapeutic decision-making will also be discussed. Read the full white paper below!